Phase 0 trial investigating the intratumoural concentration and activity of sorafenib in neurofibromatosis type 2.
Sylwia AmmounD Gareth EvansDavid A HiltonAdam J StreeterChristopher HaywardClemens O HanemannPublished in: Journal of neurology, neurosurgery, and psychiatry (2019)
Keyphrases